Literature DB >> 26970362

Cannabis and Psychosis: What Degree of Proof Do We Require?

Robin M Murray1, Marta Di Forti2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26970362     DOI： 10.1016/j.biopsych.2016.02.005

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN： 0006-3223            Impact factor:   13.382


× No keyword cloud information.
  10 in total

1.  Psychotic Symptoms in Attention-Deficit/Hyperactivity Disorder: An Analysis of the MTA Database.

Authors:  Benedetto Vitiello; Guillermo Perez Algorta; L Eugene Arnold; Andrea L Howard; Annamarie Stehli; Brooke S G Molina
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2017-02-04       Impact factor: 8.829

2.  Cannabis and Cannabinoids in Mood and Anxiety Disorders: Impact on Illness Onset and Course, and Assessment of Therapeutic Potential.

Authors:  Sabrina L Botsford; Sharon Yang; Tony P George
Journal:  Am J Addict       Date:  2019-10-02

3.  Diagnostic Difficulties and Treatment Challenges of a Young Patient With Severe Acute Psychosis and Complete Recovery.

Authors:  Jagoda Siembida; Saaduddin Mohammed; Mariam Chishty; Luba Leontieva
Journal:  Cureus       Date:  2022-04-01

4.  Genetic Predisposition vs Individual-Specific Processes in the Association Between Psychotic-like Experiences and Cannabis Use.

Authors:  Nicole R Karcher; Deanna M Barch; Catherine H Demers; David A A Baranger; Andrew C Heath; Michael T Lynskey; Arpana Agrawal
Journal:  JAMA Psychiatry       Date:  2019-01-01       Impact factor: 21.596

5.  Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis.

Authors:  Robin M Murray; Harriet Quigley; Diego Quattrone; Amir Englund; Marta Di Forti
Journal:  World Psychiatry       Date:  2016-10       Impact factor: 49.548

6.  Eye movements in patients in early psychosis with and without a history of cannabis use.

Authors:  Musa Basseer Sami; Luciano Annibale; Aisling O'Neill; Tracy Collier; Chidimma Onyejiaka; Savitha Eranti; Debasis Das; Marlene Kelbrick; Philip McGuire; Steve C R Williams; Anas Rana; Ulrich Ettinger; Sagnik Bhattacharyya
Journal:  NPJ Schizophr       Date:  2021-05-12

Review 7.  Cannabis, cannabinoids, and health.

Authors:  Genevieve Lafaye; Laurent Karila; Lisa Blecha; Amine Benyamina
Journal:  Dialogues Clin Neurosci       Date:  2017-09       Impact factor: 5.986

Review 8.  Cannabis and Psychosis: Are We any Closer to Understanding the Relationship?

Authors:  Ian Hamilton; Mark Monaghan
Journal:  Curr Psychiatry Rep       Date:  2019-06-04       Impact factor: 5.285

Review 9.  Cannabis Legalization and Acute Harm From High Potency Cannabis Products: A Narrative Review and Recommendations for Public Health.

Authors:  Justin Matheson; Bernard Le Foll
Journal:  Front Psychiatry       Date:  2020-09-23       Impact factor: 4.157

10.  Incidence of inpatient cases with mental disorders due to use of cannabinoids in Germany: a nationwide evaluation.

Authors:  Maximilian Gahr; Julia Ziller; Ferdinand Keller; Rainer Muche; Ulrich W Preuss; Carlos Schönfeldt-Lecuona
Journal:  Eur J Public Health       Date:  2022-04-01       Impact factor: 3.367
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.